|
PTCD3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.827600E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.913200E-01 |
| Normal-vs-Stage2 |
5.346800E-01 |
| Normal-vs-Stage3 |
6.944200E-02 |
| Normal-vs-Stage4 |
5.737800E-01 |
| Stage1-vs-Stage2 |
2.765200E-01 |
| Stage1-vs-Stage3 |
2.980200E-01 |
| Stage1-vs-Stage4 |
7.167000E-01 |
| Stage2-vs-Stage3 |
1.361640E-01 |
| Stage2-vs-Stage4 |
4.063200E-01 |
| Stage3-vs-Stage4 |
7.756600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.915800E-01 |
| Normal-vs-AfricanAmerican |
4.752600E-01 |
| Normal-vs-Asian |
4.171600E-01 |
| Caucasian-vs-AfricanAmerican |
9.260600E-01 |
| Caucasian-vs-Asian |
3.081200E-01 |
| AfricanAmerican-vs-Asian |
2.543200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.144000E-01 |
| Normal-vs-Female |
2.245400E-01 |
| Male-vs-Female |
1.984210E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.598200E-02 |
| Normal-vs-Extreme_Weight |
4.538900E-03 |
| Normal-vs-Obese |
8.293800E-01 |
| Normal-vs-Extreme_Obese |
4.787000E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.514600E-01 |
| Normal_Weight-vs-Obese |
1.695170E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.049200E-01 |
| Extreme_Weight-vs-Obese |
6.288200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.803240E-01 |
| Obese-vs-Extreme_Obese |
3.247200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.902000E-02 |
| Normal-vs-Age(41-60Yrs) |
8.507000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.726400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.751840E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.755250E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.246300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.179100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.144000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.118200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.707840E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.452400E-01 |
| Normal-VS-Type2 PRCC |
3.725200E-01 |
| Normal-VS-KIRP CIMP |
9.066200E-01 |
| Normal-VS-Unclassified PRCC |
7.531800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.540200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.969600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.109000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.590800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.079600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.325200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.031600E-02 |
| Normal-vs-N1 |
4.772000E-01 |
| Normal-vs-N2 |
4.645800E-01 |
| N0-vs-N1 |
4.551200E-01 |
| N0-vs-N2 |
8.415400E-01 |
| N1-vs-N2 |
6.047200E-01 |
|
|
